Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine, in healthy individuals

Masayuki Aboshi; Kenta Matsuda; Daisuke Kawakami; Kaoru Kono; Yoko Kazami; Takashi Sekida; Mai Komori; Amber L. Morey; Shigeru Suga; Jonathan F. Smith; Takasuke Fukuhara; Yasumasa Iwatani; Takuya Yamamoto; Nobuaki Sato; Wataru Akahata

doi:10.1101/2023.09.04.23294493

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine, in healthy individuals

Masayuki Aboshi, View ORCID ProfileKenta Matsuda, Daisuke Kawakami, View ORCID ProfileKaoru Kono, View ORCID ProfileYoko Kazami, View ORCID ProfileTakashi Sekida, View ORCID ProfileMai Komori, View ORCID ProfileAmber L. Morey, Shigeru Suga, View ORCID ProfileJonathan F. Smith, View ORCID ProfileTakasuke Fukuhara, View ORCID ProfileYasumasa Iwatani, View ORCID ProfileTakuya Yamamoto, View ORCID ProfileNobuaki Sato, View ORCID ProfileWataru Akahata

doi: https://doi.org/10.1101/2023.09.04.23294493

Masayuki Aboshi

1VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kenta Matsuda

2VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kenta Matsuda

Daisuke Kawakami

1VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kaoru Kono

1VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Kaoru Kono

Yoko Kazami

1VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yoko Kazami

Takashi Sekida

1VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Takashi Sekida

Mai Komori

2VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Mai Komori

Amber L. Morey

2VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Amber L. Morey

Shigeru Suga

3National Hospital Organization, Mie National Hospital, Tsu, Mie 514-0125, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jonathan F. Smith

2VLP Therapeutics, Inc., Gaithersburg, MD 20878, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jonathan F. Smith

Takasuke Fukuhara

4Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido 060-0815, Japan

5Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Takasuke Fukuhara

Yasumasa Iwatani

6Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi 460-0001, Japan

7Division of Basic Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Yasumasa Iwatani

Takuya Yamamoto

8Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka 567-0085, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Takuya Yamamoto

Nobuaki Sato

1VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nobuaki Sato

Wataru Akahata

1VLP Therapeutics Japan, Inc., 1-16-4 Nishi-Shinbashi, Minato-ku, Tokyo 105-0003, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Wataru Akahata
For correspondence: wakahata@vlptherapeutics.com

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

View the discussion thread.

PreviousNext

Posted September 06, 2023.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine, in healthy individuals

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine, in healthy individuals

Masayuki Aboshi, Kenta Matsuda, Daisuke Kawakami, Kaoru Kono, Yoko Kazami, Takashi Sekida, Mai Komori, Amber L. Morey, Shigeru Suga, Jonathan F. Smith, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Nobuaki Sato, Wataru Akahata

medRxiv 2023.09.04.23294493; doi: https://doi.org/10.1101/2023.09.04.23294493

Share This Article: